Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 49.68% is 30% below its 5-year average of 71.37%, around the middle of its 5-year range (12.33%–94.30%).
17.81% above its 12-month average of 42.17%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 14.73%.
GROSS MARGIN
49.68%
GROSS MARGIN AVG TTM
42.17%
GROSS MARGIN AVG 3Y
66.22%
GROSS MARGIN AVG 5Y
71.37%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+17.81%
CURRENT VS 3Y AVG
-24.98%
CURRENT VS 5Y AVG
-30.39%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+20.06%
vs the sector median at left
Scilex Holding Company
Market Cap
$33.58M
Gross Margin
49.68%
TTM Avg
42.17%
3Y Avg
66.22%
5Y Avg
71.37%
Market Cap
$33.33M
Gross Margin
27.73%
TTM Avg
29.89%
3Y Avg
31.55%
5Y Avg
33.94%
Market Cap
$33.60M
Gross Margin
57.46%
TTM Avg
78.73%
3Y Avg
89.36%
5Y Avg
76.24%
Market Cap
$34.50M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
10.20%
Market Cap
$32.17M
Gross Margin
17.71%
TTM Avg
17.06%
3Y Avg
12.53%
5Y Avg
8.43%
Market Cap
$31.44M
Gross Margin
16.44%
TTM Avg
14.13%
3Y Avg
15.03%
5Y Avg
13.67%
Market Cap
$35.15M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scilex Holding Company (SCLX) | $33.58M | 49.68% | 42.17% | 66.22% | 71.37% |
| Accuray Incorporated (ARAY)vs › | $33.33M | 27.73% | 29.89% | 31.55% | 33.94% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.60M | 57.46% | 78.73% | 89.36% | 76.24% |
| HeartBeam, Inc. (BEAT)vs › | $33.87M | 0.00% | 0.00% | 0.00% | 0.00% |
| Elutia Inc (ELUT)vs › | $34.48M | 57.82% | 48.80% | 47.77% | 46.56% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.50M | 0.00% | 0.00% | 0.00% | 10.20% |
| Rockwell Medical, Inc. (RMTI)vs › | $32.17M | 17.71% | 17.06% | 12.53% | 8.43% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 16.44% | 14.13% | 15.03% | 13.67% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| DocGo Inc. (DCGO)vs › | $35.57M | 30.12% | 32.64% | 32.93% | 33.24% |
Gross Margin
49.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 14.73% |
| 2026-03-31 | 48.37% |
| 2025-12-31 | 12.33% |
| 2025-09-30 | 68.48% |
| 2025-06-30 | 66.94% |
| 2025-03-31 | 72.34% |
| 2024-12-31 | 68.52% |
| 2024-09-30 | 73.90% |
| 2024-06-30 | 73.18% |
| 2024-03-31 | 64.72% |
| 2023-12-31 | 58.74% |
| 2023-09-30 | 66.47% |
| 2023-06-30 | 66.80% |
| 2023-03-31 | 66.07% |
| 2022-12-31 | 62.14% |
| 2022-09-30 | 68.26% |
| 2022-06-30 | 80.71% |
| 2022-03-31 | 83.21% |
| 2021-12-31 | 86.87% |
| 2021-09-30 | 85.92% |
| 2021-06-30 | 94.30% |
| 2021-03-31 | 84.56% |
| 2020-12-31 | 90.88% |
| 2020-09-30 | 90.88% |
| 2020-06-30 | 90.88% |
| 2020-03-31 | 90.88% |
| 2019-12-31 | 72.41% |
| 2019-09-30 | 72.41% |
| 2019-06-30 | 72.41% |
| 2019-03-31 | 72.41% |
